CARL · Carlsmed, Inc.
AI read · Bad for CARL
The AI's read
If the court agrees with DeGen, Carlsmed could lose much of its case and its chance to seek extra damages. The motion challenges the core method claims and also targets its willfulness claim. No court ruling is reported, so the filing is a risk, not a loss in court.